Expert Board Meeting

29-30 November 2018, Brussels, Belgium

Focus: Consensus on the positioning of Biological therapies for CRSwNP & Asthma

This closed expert board meeting represents a key milestone for the positioning of biological treatments for chronic rhinosinusitis with nasal polyps (CRSwNP) and Asthma. The purpose of the meeting is to find a consensus between experts from the upper and lower airways. The faculty will consist of ~25 international experts (US & EU) from various specialisms, both junior and senior. Patients with CRSwNP and asthma will also attend the consensus meeting to bring their insights.